The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy.

导出 OA

翻译打印收藏纠错

作者： Hyun-Jeong,Shim ^[1] ; Min-Ho,Shin ^[2] ; Hee-Nam,Kim ^[3] ; Jo-Heon,Kim ^[4] ; Jun-Eul,Hwang ^[1] ; Woo-Kyun,Bae ^[1] ; Ik-Joo,Chung ^[1] ; Sang-Hee,Cho ^[1]

作者单位： Department of Hemato-Oncology, Chonnam National University Medical School, Hwasun, Korea. ^[1] Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea ; Department of Jeonnam Regional Cancer Center, Chonnam National University Medical School, Hwasun, Korea. ^[2] Department of Jeonnam Regional Cancer Center, Chonnam National University Medical School, Hwasun, Korea. ^[3] Department of Pathology, Chonnam National University Medical School, Hwasun, Korea. ^[4]

关键词 Biological markers Chemoradiotherapy Esophageal neoplasms Fibroblast growth factor receptor 4

主题词无病生存(Disease-Free Survival);食管肿瘤(Esophageal Neoplasms);人类(Humans);多态现象, 遗传(Polymorphism, Genetic);预后(Prognosis);受体, 成纤维细胞生长因子, 4型(Receptor, Fibroblast Growth Factor, Type 4)

DOI 10.4143/crt.2015.018

PMID 25989802

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交